在宫癌中,EIF3B-METTL3复合物促进细胞增殖,入侵和EGFR/AKT信号传递
Chao Zhang1, Xiang Fan1, Jia Yang1
1Department of Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu 213000, P.R. China.
Oncology reports
|June 27, 2025
概括
细胞转化启动因子3B (EIF3B) 和甲基转移酶类3 (METTL3) 复合物通过增加细胞增殖和侵入来促进子宫癌. 这种EIF3B-METTL3相互作用激活了EGFR/AKT通路,推动了癌症的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞转化启动因子3B (EIF3B) 与甲基转移酶类 (METTL) 蛋白相互作用,影响癌症的发展.
- 在宫癌 (CC) 中,EIF3B和METTL3之间的特定相互作用机制仍然未被阐明.
研究的目的:
- 在宫癌细胞中研究EIF3B和METTL3之间的相互作用.
- 确定EIF3B和METTL3在CC细胞恶性行为和EGFR/AKT信号通路中的调节作用.
主要方法:
- 在HeLa和SiHa CC细胞系中感染EIF3B过度表达等离子体 (oeEIF3B) 和siRNA (siEIF3B,siMETTL3).
- 同免疫沉试验证实了EIF3B-METTL3复合体的形成.
- 细胞增殖,侵入和细胞亡的评估,以及EGFR/AKT通路分析.
主要成果:
- 在CC细胞系中,EIF3B的表达得到了上调.
- 过度表达EIF3B增强了扩散和入侵,同时抑制了亡; siEIF3B有相反的效果.
- EIF3B-METTL3复合体,而不是单独的EIF3B,对于促进CC细胞增殖,入侵和EGFR/AKT通路激活至关重要,同时抑制细胞亡.
结论:
- EIF3B和METTL3形成一个复合体,驱动子宫癌的进展.
- 通过激活EGFR/AKT信号通路,EIF3B-METTL3复合体促进细胞的增殖和侵入.
- 针对EIF3B-METTL3相互作用,为宫癌提供了一个潜在的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K


